| Year |
Citation |
Score |
| 2023 |
Young Jang M, Patel PN, Pereira AC, Willcox JAL, Haghighi A, Tai AC, Ito K, Morton SU, Gorham JM, McKean DM, DePalma SR, Bernstein D, Brueckner M, Chung WK, Giardini A, et al. Contribution of Previously Unrecognized RNA Splice-Altering Variants to Congenital Heart Disease. Circulation. Genomic and Precision Medicine. e003924. PMID 37165897 DOI: 10.1161/CIRCGEN.122.003924 |
0.47 |
|
| 2022 |
Willcox JAL, Geiger JT, Morton SU, McKean D, Quiat D, Gorham JM, Tai AC, DePalma S, Bernstein D, Brueckner M, Chung WK, Giardini A, Goldmuntz E, Kaltman JR, Kim R, et al. Neither cardiac mitochondrial DNA variation or copy number contribute to congenital heart disease risk. American Journal of Human Genetics. PMID 35397206 DOI: 10.1016/j.ajhg.2022.03.011 |
0.459 |
|
| 2022 |
Gonzalez-Teran B, Pittman M, Felix F, Thomas R, Richmond-Buccola D, Hüttenhain R, Choudhary K, Moroni E, Costa MW, Huang Y, Padmanabhan A, Alexanian M, Lee CY, Maven BEJ, Samse-Knapp K, ... Morton SU, et al. Transcription factor protein interactomes reveal genetic determinants in heart disease. Cell. PMID 35182466 DOI: 10.1016/j.cell.2022.01.021 |
0.511 |
|
| 2020 |
Morton SU, Shimamura A, Newburger PE, Opotowsky AR, Quiat D, Pereira AC, Jin SC, Gurvitz M, Brueckner M, Chung WK, Shen Y, Bernstein D, Gelb BD, Giardini A, Goldmuntz E, et al. Association of Damaging Variants in Genes With Increased Cancer Risk Among Patients With Congenital Heart Disease. Jama Cardiology. PMID 33084842 DOI: 10.1001/jamacardio.2020.4947 |
0.442 |
|
| 2020 |
Sharma A, Wasson LK, Willcox JA, Morton SU, Gorham JM, DeLaughter DM, Neyazi M, Schmid M, Agarwal R, Jang MY, Toepfer CN, Ward T, Kim Y, Pereira AC, DePalma SR, et al. utations in hiPSCs inform mechanisms for maldevelopment of the heart, pancreas, and diaphragm. Elife. 9. PMID 33054971 DOI: 10.7554/eLife.53278 |
0.506 |
|
| 2020 |
Boskovski MT, Homsy J, Nathan M, Sleeper LA, Morton S, Manheimer KB, Tai A, Gorham J, Lewis M, Swartz M, Alfieris GM, Bacha EA, Karimi M, Meyer D, Nguyen K, et al. De Novo Damaging Variants, Clinical Phenotypes, and Post-Operative Outcomes in Congenital Heart Disease. Circulation. Genomic and Precision Medicine. 13: e002836. PMID 32812804 DOI: 10.1161/CIRCGEN.119.002836 |
0.471 |
|
| 2020 |
Richter F, Morton SU, Kim SW, Kitaygorodsky A, Wasson LK, Chen KM, Zhou J, Qi H, Patel N, DePalma SR, Parfenov M, Homsy J, Gorham JM, Manheimer KB, Velinder M, et al. Genomic analyses implicate noncoding de novo variants in congenital heart disease. Nature Genetics. PMID 32601476 DOI: 10.1038/S41588-020-0652-Z |
0.517 |
|
| 2020 |
Hsieh A, Morton SU, Willcox JAL, Gorham JM, Tai AC, Qi H, DePalma S, McKean D, Griffin E, Manheimer KB, Bernstein D, Kim RW, Newburger JW, Porter GA, Srivastava D, et al. EM-mosaic detects mosaic point mutations that contribute to congenital heart disease. Genome Medicine. 12: 42. PMID 32349777 DOI: 10.1186/S13073-020-00738-1 |
0.523 |
|
| 2019 |
O'Connell AE, Gerashchenko MV, O'Donohue MF, Rosen SM, Huntzinger E, Gleeson D, Galli A, Ryder E, Cao S, Murphy Q, Kazerounian S, Morton SU, Schmitz-Abe K, Gladyshev VN, Gleizes PE, et al. Mammalian Hbs1L deficiency causes congenital anomalies and developmental delay associated with Pelota depletion and 80S monosome accumulation. Plos Genetics. 15: e1007917. PMID 30707697 DOI: 10.1371/Journal.Pgen.1007917 |
0.318 |
|
| 2019 |
Sharma A, Wasson L, Willcox J, Morton SU, Gorham JM, DeLaughter DM, Neyazi M, Schmid M, Agarwal R, Jang M, Toepfer CN, Ward T, Kim Y, Pereira AC, DePalma SR, et al. Abstract 785: Modeling Congenital Heart Disease-Associated Variants in
GATA6
Using CRISPR/Cas9 and Human Induced Pluripotent Stem Cells Circulation Research. 125. DOI: 10.1161/Res.125.Suppl_1.785 |
0.348 |
|
| 2017 |
Jin SC, Homsy J, Zaidi S, Lu Q, Morton S, DePalma SR, Zeng X, Qi H, Chang W, Sierant MC, Hung WC, Haider S, Zhang J, Knight J, Bjornson RD, et al. Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands. Nature Genetics. PMID 28991257 DOI: 10.1038/Ng.3970 |
0.53 |
|
| 2017 |
Cao S, Smith LL, Padilla-Lopez SR, Guida BS, Blume E, Shi J, Morton SU, Brownstein CA, Beggs AH, Kruer MC, Agrawal PB. Homozygous EEF1A2 mutation causes dilated cardiomyopathy, failure to thrive, global developmental delay, epilepsy and early death. Human Molecular Genetics. 26: 3545-3552. PMID 28911200 DOI: 10.1093/Hmg/Ddx239 |
0.366 |
|
| 2015 |
Morton SU, Joshi M, Savic T, Beggs AH, Agrawal PB. Skeletal muscle microRNA and messenger RNA profiling in cofilin-2 deficient mice reveals cell cycle dysregulation hindering muscle regeneration. Plos One. 10: e0123829. PMID 25874796 DOI: 10.1371/Journal.Pone.0123829 |
0.385 |
|
| 2015 |
Morton S, Roberts AE. Genetic Basis of Congenital Heart Disease Neoreviews. 16: e340-e350. DOI: 10.1542/Neo.16-6-E340 |
0.371 |
|
| 2009 |
Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN, Srivastava D. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature. 460: 705-10. PMID 19578358 DOI: 10.1038/Nature08195 |
0.539 |
|
| 2008 |
Morton SU, Scherz PJ, Cordes KR, Ivey KN, Stainier DY, Srivastava D. microRNA-138 modulates cardiac patterning during embryonic development. Proceedings of the National Academy of Sciences of the United States of America. 105: 17830-5. PMID 19004786 DOI: 10.1073/Pnas.0804673105 |
0.598 |
|
| 2008 |
Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY, Srivastava D. miR-126 regulates angiogenic signaling and vascular integrity. Developmental Cell. 15: 272-84. PMID 18694566 DOI: 10.1016/J.Devcel.2008.07.008 |
0.58 |
|
| Show low-probability matches. |